Glaxo accused of market 'abuse'

Home › Glaxo accused of market 'abuse'

The Office of Fair Trading accuses GlaxoSmithKline of paying rivals to delay the release of generic versions of one of its drugs.

22.11	'Scammers sent courier to steal 4,000'
22.11	Spain fines budget airlines including Ryanair 179m
22.11	Formulating Biphasic and Triphasic Products
22.11	Gatwick terminal evacuated due to security risk
22.11	68% of US households have a smart TV, 46% have a streaming media player
22.11	Reliance and Disney complete India JV transaction
22.11	HbbTV Association appoints Service List Registry
22.11	ocilion brings Prime Video and YouTube to its IPTV platform
Consumer Goods and Services »

je.st